Recce Pharmaceuticals Ltd (ASX:RCE) has been awarded over $17 million

Latest Company News - Finance News Network

English - November 26, 2020 00:30 - 52 seconds - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Gentrack Group Limited (ASX:GTK) report EBITDA down 51%

Next Episode: AnteoTech (ASX:ADO) to receive $1.2M tax refund

26 Nov 2020 - Recce Pharmaceuticals Ltd (ASX:RCE) has been awarded over $17 million of Synthetic Antibiotic Research & Development applicable expenditure by AusIndustry.